KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Operating Expenses (2016 - 2025)

Quest Diagnostics' Operating Expenses history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • For Q4 2025, Operating Expenses rose 7.08% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $9.5 billion, up 11.18%, while the annual FY2025 figure was $9.5 billion, 11.18% up from the prior year.
  • Operating Expenses for Q4 2025 was $2.4 billion at Quest Diagnostics, roughly flat from $2.4 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.4 billion in Q3 2025 and bottomed at $2.0 billion in Q3 2023.
  • The 5-year median for Operating Expenses is $2.1 billion (2022), against an average of $2.1 billion.
  • The largest annual shift saw Operating Expenses soared 30.63% in 2021 before it decreased 8.05% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $2.2 billion in 2021, then dropped by 0.45% to $2.2 billion in 2022, then decreased by 8.05% to $2.0 billion in 2023, then increased by 11.83% to $2.3 billion in 2024, then increased by 7.08% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Operating Expenses are $2.4 billion (Q4 2025), $2.4 billion (Q3 2025), and $2.3 billion (Q2 2025).